Objective. To summarize major complications and outcome for patients receiving
percutaneous closure of atrial septal communications. Design. The Medline database and …

The Amplatzer septal occluder (ASO) is used for transcatheter closure of atrial septal defects
(ASDs). This study aimed to determine the factors influencing successful closure with the …

The objective of this study was to determine the initial safety and results of unrestricted multi-
institution routine community use of the Amplatzer Septal Occluder (ASO) for atrial septal …

OBJECTIVE: Amplatzer (AGA Medical Corporation, Plymouth, Minn) septal and vascular
occluder devices have significantly altered the care of patients with congenital heart …

OBJECTIVE: This study reports the procedural, short and medium term outcomes in patients
receiving multiple implants for device closure of secundum atrial septal defects (ASD) …

Atrial septal defect (ASD) is one of the most common congenital heart defects requiring
procedural intervention. In such cases, transcatheter closure of secundum ASDs has been …

AIM: To report the results of transcatheter atrial septal defect (ASD) closure with the
Amplatzer septal occluder (ASO) from the single centre providing interventions for …

Objectives: The goal of this study was to report the early and late complications experienced
in atrial septal defect (ASD) transcatheter closure. Background: Atrial septal defect …

The objectives of this study were to identify possible risk factors that may lead to erosion of
the Amplatzer septal occluder (ASO) and recommend ways to minimize future risk. There …

Transcatheter Device Closure of Atrial Septal Defects: A Safety Review | JACC:
Cardiovascular Interventions Skip to main content JACC Journals Search Search All …